796 related articles for article (PubMed ID: 4183680)
1. Breakdown products of C 3 in human synovial fluids.
Zvaifler NJ
J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
[TBL] [Abstract][Full Text] [Related]
2. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
[TBL] [Abstract][Full Text] [Related]
3. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
5. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
Alper CA; Rosen FS
J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
[TBL] [Abstract][Full Text] [Related]
6. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
7. Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.
Winchester RJ; Agnello V; Kunkel HG
Clin Exp Immunol; 1970 May; 6(5):689-706. PubMed ID: 4097828
[TBL] [Abstract][Full Text] [Related]
8. [Research on non-hemolytic (immuno-adherent) complement and on the 3d component of complement (C'3) in the synovial liquid during inflammatory rheumatism].
Peltier AP
Rev Fr Etud Clin Biol; 1968 Apr; 13(4):351-9. PubMed ID: 5682745
[No Abstract] [Full Text] [Related]
9. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. II. Demonstration of an abnormal anti-complement property in rheumatoid synovial fluids].
Peltier AP; Vial MC; Leroy C; de Sèze S
Pathol Biol (Paris); 1970 Nov; 18(21):969-74. PubMed ID: 4099022
[No Abstract] [Full Text] [Related]
10. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. I. Variations in the levels of C'1, C'4, C'2 and C'3 and total complement].
Peltier AP; Vial MC; de Sèze S
Pathol Biol (Paris); 1970 Nov; 18(21):959-67. PubMed ID: 4921319
[No Abstract] [Full Text] [Related]
11. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
da Silva WD; Eisele JW; Lepow IH
J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
[TBL] [Abstract][Full Text] [Related]
12. Studies on synovial fluid in arthritis. I. The total complement activity. II. The occurrence of mononuclear cells with in vitro cytotoxic effect.
Hedberg H
Acta Med Scand Suppl; 1967; 479():1-137. PubMed ID: 4172267
[No Abstract] [Full Text] [Related]
13. Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions.
Hannestad K
Clin Exp Immunol; 1967 Jul; 2(4):511-29. PubMed ID: 4167751
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
Perrin LH; Shiraishi S; Stroud RM; Lambert PH
J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
Naama JK; Mitchell WS; Whaley K
Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
[TBL] [Abstract][Full Text] [Related]
16. A study of complement fixation by rheumatoid factor using a haemolytic assay system.
Taylor-Upsahl MM; Johnson PM; Mellbye OJ; Natvig JB
Clin Exp Immunol; 1977 May; 28(2):204-11. PubMed ID: 872448
[TBL] [Abstract][Full Text] [Related]
17. [Changes in the synovial membrane in early diagnosed cases of rheumatoid arthritis. II. Immunohistochemical and serological studies].
Emmrich J; Geiler G
Z Rheumatol; 1980; 39(5-6):157-69. PubMed ID: 7415585
[TBL] [Abstract][Full Text] [Related]
18. Complement fixation by rheumatoid factor.
Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
[TBL] [Abstract][Full Text] [Related]
19. IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources.
Bhardwaj N; Santhanam U; Lau LL; Tatter SB; Ghrayeb J; Rivelis M; Steinman RM; Sehgal PB; May LT
J Immunol; 1989 Oct; 143(7):2153-9. PubMed ID: 2789256
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein.
Marcus RL; Townes AS
J Clin Invest; 1971 Feb; 50(2):282-93. PubMed ID: 4992991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
